Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALIRIFOX with PD-1 and Radiotherapy in Locally Advanced Pancreatic Cancer
NCT06669078Phase 2Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Oct 2024
- Primary completion
- Oct 2027
01
Overview
Phase 2, randomised, open-label trial in pancreatic cancer (PC), sponsored by Nanjing Drum-Tower Hospital. Planned start Oct 2024; status: not yet recruiting.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06669078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06669078.